SCHEMBL633197

SCHEMBL633197

O=C(O)c1cccc(Cc2cccc(C(=O)O)c2O)c1O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGB1 P09429 3/20 0.67
ALDH1A1 P00352 4/20 0.55
HPGD P15428 3/20 0.55
HSD17B10 Q99714 2/20 0.55
KDM4E B2RXH2 2/20 0.55
ALB P02768 1/20 0.55
MMP2 P08253 1/20 0.55
PTPN1 P18031 6/20 0.55
PTPN2 P17706 2/20 0.55
PTPN6 P29350 2/20 0.55
HNF4A P41235 1/20 0.52
CXCL12 P48061 1/20 0.52
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.47
FOLH1 Q04609 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29697016 1.00 HMGB1 (0.67) HMGB1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL1560171 0.91 HMGB1 (0.57) HMGB1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL1161183 0.91 HMGB1 (0.57) HMGB1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL2467709 0.89 HMGB1 (0.56) HMGB1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL2473330 0.89 HMGB1 (0.56) HMGB1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL112902 0.88 PTPN1 (0.65) HMGB1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL30612910 0.88 PTPN1 (0.65) HMGB1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL11327561 0.88 HMGB1 (0.54) HMGB1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL1396288 0.88 HPGD (0.62) HMGB1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL6447233 0.88 HMGB1 (0.54) HMGB1ALDH1A1HPGDHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 644 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117586479-A Curing agent for epoxy resin and epoxy resin composition 味之素株式会社 2024-02-23 CN claimed
CN-114230639-A Preparation method of bacitracin methylene disalicylate 齐鲁制药(内蒙古)有限公司 2022-03-25 CN claimed
CN-112159584-A Composite anti-condensation polyurethane sealing element and preparation method thereof 安徽火峰电气有限公司 2021-01-01 CN claimed
CN-103923765-A Detergent Composition For Process Of Manufacturing Semiconductors And Displays COWON INNOTECH INC 2014-07-16 CN claimed
US-20120093759-A1 Medical Devices, Wound Dressings, and Methods for Dressing Wounds VACHON DAVID J (US) 2012-04-19 US claimed
US-20100310597-A1 ANTI-OFLOXACIN MONOCLONAL ANTIBODY AND IMMUNOASSAY OF OFLOXACIN USING THE SAME SEKISUI MEDICAL CO., LTD 2010-12-09 US claimed
EP-2233503-A1 ANTI-OFLOXACIN MONOCLONAL ANTIBODY AND IMMUNOASSAY METHOD OF OFLOXACIN USING THE SAME Sekisui Medical Co., Ltd. (JP) 2010-09-29 EP claimed
EP-1836190-A2 PREPARATION OF PHARMACEUTICAL SALTS OF PIPERAZINE COMPOUNDS SCHERING CORPORATION (US) 2007-09-26 EP claimed
US-20060241295-A1 Preparation of pharmaceutical salts of piperazine compounds SCHERING CORPORATION 2006-10-26 US claimed
WO-2006074269-A2 PREPARATION OF PHARMACEUTICAL SALTS OF PIPERAZINE COMPOUNDS SCHERING CORPORATION (US) 2006-07-13 WO claimed
EP-0924270-A1 Wrinkle finish powder coating with pattern control MORTON INTERNATIONAL, INC. (US) 1999-06-23 EP claimed
US-5795927-A BLEND CONTAINING COLOR STABILIZER MORTON INTERNATIONAL, INC. (US) 1998-08-18 US claimed
US-5780560-A Epoxy powder coating with wrinkle finish MORTON INTERNATIONAL, INC. (US) 1998-07-14 US claimed
US-5688878-A CURABLE COATINGS WITH METHYLENEDISALICYLIC ACID AND SULFURIC ACID MORTON INTERNATIONAL, INC. (US) 1997-11-18 US claimed
WO-1997004770-A1 2-(FLUORENONYL)-CARBAPENEMS, COMPOSITIONS AND METHODS OF USE MERCK & CO., INC. (US) 1997-02-13 WO claimed
US-5451579-A 1-β-methyl-carbapenem, compositions containing same and methods of use MERCK & CO., INC. (US) 1995-09-19 US claimed
WO-1995021841-A1 1-β-METHYL-CARBAPENEM, COMPOSITIONS CONTAINING SAME AND METHODS OF USE MERCK & CO., INC. (US) 1995-08-17 WO claimed
EP-0022701-A1 Improved poly(alkylene oxide) compositions containing a bridged dimer of a hydroxylsubstituted aromatic carboxylic acid or a salt thereof UNION CARBIDE CORPORATION (US) 1981-01-21 EP claimed
US-4120762-A POROUS SUPPORT IMPREGNATED WITH AN ELECTROLYTE, A MARKING COMPOUND AND A NITROGEN-CONTAINING SIX-MEMBERED HETEROCYCLIC AROMATIC CARBOXY ACID ALDEN RESEARCH FOUNDATION (US) 1978-10-17 US claimed
US-4001027-A FLUORESCEIN TYPE PIGMENT BORDEN, INC. (US) 1977-01-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241295-A1 Preparation of pharmaceutical salts of piperazine compounds ADCYAP1R1, CYP3A5, RAP2C HMGB1 4844/4885ALDH1A1 847/4885HPGD 442/4885
US-20100310597-A1 ANTI-OFLOXACIN MONOCLONAL ANTIBODY AND IMMUNOASSAY OF OFLOXACIN USING THE SAME CYP2D6, CYP2F1, NQO2 HMGB1 1645/4885ALDH1A1 1028/4885HPGD 202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.